Prelude Capital Management’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,914
| Closed | -$55K | – | 2439 |
|
|
2019
Q3 | $55K | Buy |
+2,914
| New | +$33.3K | ﹤0.01% | 1138 |
|
|
2018
Q1 | – | Sell |
-48,767
| Closed | -$558K | – | 1841 |
|
|
2017
Q4 | $558K | Sell |
48,767
-6,052
| -11% | -$67.6K | 0.04% | 391 |
|
|
2017
Q3 | $672K | Sell |
54,819
-31,873
| -37% | -$332K | 0.06% | 313 |
|
|
2017
Q2 | $993K | Buy |
86,692
+71,504
| +471% | +$1.32M | 0.09% | 221 |
|
|
2017
Q1 | $316K | Buy |
+15,188
| New | +$336K | 0.03% | 423 |
|
|
2016
Q4 | – | Sell |
-16,162
| Closed | -$530K | – | 1909 |
|
|
2016
Q3 | $530K | Buy |
+16,162
| New | +$492K | 0.06% | 300 |
|
|
2016
Q1 | – | Sell |
-7,000
| Closed | -$231K | – | 1655 |
|
|
2015
Q4 | $231K | Buy |
7,000
+5,800
| +483% | +$196K | 0.04% | 494 |
|
|
2015
Q3 | $39K | Hold |
1,200
| – | – | 0.01% | 1120 |
|
|
2015
Q2 | $64K | Buy |
1,200
+500
| +71% | +$18.2K | 0.01% | 1062 |
|
|
2015
Q1 | $20K | Sell |
700
-400
| -36% | -$11K | ﹤0.01% | 1752 |
|
|
2014
Q4 | $32K | Buy |
+1,100
| New | +$19.7K | ﹤0.01% | 1606 |
|